 |
 |
TVP 1012 was developed by Rappaport Family Institute for Research and Teva Pharmaceutical Industries (both in Israel) to "combat" PD. FDA has given the approval for clinical studies in addition to clinical studies in Europe and Israel. Is anyone aware of this drug, how it "alleviates" PD and where any of the clinical trials will be held? This is the total of my information taken from a newsletter by Technion-Iisrael Institute of Technology. Les McCoun (using my wife's address) [log in to unmask]